Another study using HCC-PDX humanized mouse model demonstrated the anti-HCC effect of anti-GPC3 CAR-T cell therapy [92], providing more evidence on the importance of these models for the testing of novel combinatorial therapeutic strategies. The gene discussed is GPC3; the disease is hepatocellular carcinoma.